Effect of Octreotide* on SS-R-Positive CA-20948 Liver Metastases After Sham Operation or 70% Partial Hepatectomy
↵* 50 μg/kg subcutaneously, twice daily.
↵† <50% of liver affected.
↵‡ >50% of liver affected.
↵§ P < 0.01 vs. sham operation.
Values in parentheses are SEM.